All News

Sweeping changes to the way America delivers care at the end of life would better serve patients and their families while bringing the healthcare savings that managed care has long sought, according to the Institute of Medicine report, "Dying in America," which was released yesterday.

After examining the security and privacy of the Healthcare.gov website and its supporting systems at CMS, the Government Accountability Office published a report with 6 security management and 22 technical security recommendations.

The study, published in Lancet Oncology, found that ramucirumab significantly improved survival by over 2 months.

As part of National Health IT Week, the Office of the National Coordinator for Health IT, outlined its 10-year vision to achieve interoperability for health IT.

The study, published this week in Nature Genetics, is the product of an international collaboration that has identified 23 new loci that could lead to an increased risk of developing prostate cancer.

Although approved last September in the European Union, the National Institute for Health and Care Excellence had refused to cover the drug at the company-dictated price, which resulted in patients paying out-of-pocket.

Novo Nordisk's new long-acting insulin, Tresiba, has been shown to be effective and safe for long-term use in children and young adults with type 1 diabetes, according to new data from a late-stage trial presented on Tuesday.

A study published today found that 16 major U.S. food companies that pledged to cut calories from foods sold consumers cut 6.4 million calories, or 10.6 percent, over a five-year period ending in 2012. Authors of the study say the results show that selling Americans healthier food need not be at odds with a healthy bottom line, and that "the results should encourage other manufacturers and retailers to follow suit."

In a study of 3 hospitals in Massachusetts, more than a quarter of patient orders were considered partially defensive medicine, but they only accounted for 13% of costs.

The study, published in the Journal of Clinical Oncology, wants a policy revamp on screening guidelines for the women who fall in this category.

Anthem Blue Cross is partnering with 7 rival hospital systems in California to create a new integrated health system in the Los Angeles and Orange counties. The members will share financial risk and gain.

The antibody, an inhibitor of the enzyme lysyl oxidase-like-2, combined with gemcitabine, did not have a significant effect on progression-free survival compared to the placebo with gemcitabine arm, in pancreatic cancer patients.

The American Medical Association has released a framework to improve usability of electronic health records so as to benefit the patients and providers.

Research presented at the 56th Annual Meeting of the American Society for Radiation Oncology identified VEGF-A and TGF-beta as markers of treatment decision in patients with esophageal squamous cell carcinoma.

During the second year of the program, Medicare accountable care organizations reported improvements in nearly all of the quality and patient experience measures, according to data reported by CMS.

Gilead has licensed sofosbuvir to drugmakers in India who will sell cheaper versions of this revolutionary treatment in 91 developing nations.

Ascension Health will form a joint venture with a division of Envision Healthcare to provide an array of post-acute services, including home care, hospice care, and infusion therapy.

The results of a phase 1b study, presented at the AACR special conference "Targeting the PI3K-mTOR Network in Cancer," found that Alpelisib could overcome resistance to the anti-EGFR antibody cetuximab, and the two regimens together were quite beneficial.

A study published in the Annals of Internal Medicine, the result of a collaboration between CVS Caremark and scientists at the Brigham and Women's Hospital and the Harvard Medical School, compared patient adherence to brand name versus generic statins.

The federal government will terminate health insurance coverage under the Affordable Care Act for 115,000 individuals who failed to prove they were United States citizens or legal immigrants. Furthermore, another 363,000 people could lose their financial aid because of income reporting discrepancies.

Deaths from overdoses of prescription painkillers are not rising as quickly, but the reasons for that trend are unclear and could be linked to the legalization of marijuana, according to reports released today.

In the wake of Advocate Health Care and NorthShore University HealthSystem's proposed merger, America's Health Insurance Plans is leading the charge to prevent this and similar mergers and acquisitions.

MicroRNAs have the potential to be predictive biomarkers that can predict survival as well as response to chemotherapy, as this study discovered.

This recommendation follows the list of 5 released last year by the organization, with the aim of helping the patient and physician choose appropriate treatments.

Following Herceptin earlier this year, Roche has announced that tampered vials of it's blood cancer drug MabThera (Rituxan) were found in Germany.

Despite the current high cost of Gilead Science's hepatitis C drug, the next generation version will be even more expensive. However, the company also struck deals with generic drugmakers to bring the drug to developing countries.

Weighing the cost-benefit ratio of proton radiation therapy, private and public payers are placing coverage limitations on the use of this treatment.

More than 1,000 health centers in every US state and territory will receive Affordable Care Act funds to expand their primary care services, according to an announcement from Health and Human Services' Secretary Sylvia M. Burwell.

Open enrollment season is almost upon us. That will bring a test of whether the website for the federal exchange, HealthCare.gov can perform better in its second year than in its disastrous debut.

Rapid advances in detection technology, coupled with an increased awareness about screening, have ignited a debate on overdiagnosis and overtreatment of precancerous lesions. Should physicians use their discretion and implement a "wait-and-watch" approach?